Studies point to new genes associated with MS risk
The studies, conducted by teams of scientists working all over the world, will help shed light on the causes of multiple sclerosis (MS) according to the researchers. Both

The studies, conducted by teams of scientists working all over the world, will help shed light on the causes of multiple sclerosis (MS) according to the researchers. Both

Gene Logic discovered the new potential therapeutic use for the candidate, GL1001, using its drug repositioning platform, a set of drug evaluation technologies the company uses to assess

Medivation has expanded patient enrollment in the trial by 20% – to 90 patients – in order to enhance the ability to detect differences between Dimebon and placebo.

The vaccine, the first of its kind for 80 years, is needed following a global rise in TB outbreaks. In the UK alone, there has been a 10%

The program, called a treatment IND, is designed to help women in the US under 55 years of age who suffer from irritable bowel syndrome with constipation (IBS-C)

Under this amendment, the companies have jointly agreed to expand the investment in the ongoing clinical development plan for Erbitux by up to several hundred million dollars. Development

Biogen Idec and Elan have submitted studies to support their bid for approval. However, documents on the FDA website reveal that they did not show Tysabri to be

Conducted by a team of researchers in Denmark, the study focused on ovariectomized rats, a model that closely resembles the changes in the human skeletal system during menopause.

Around 26,000 people develop wet AMD in the UK each year, and the disease can cause impaired vision, leading to blindness. The National Institute for Health and Clinical

In a clinical study, Vyvanse provided consistent ADHD symptom control throughout the day based upon parent reports in the morning (approximately 10am), afternoon (approximately 2pm), and early evening